| Early Career Professional Welcome | |||||
|
Tue19 Oct08:00am(45 mins)
|
|
Dr Lisa Stott | |||
| Session : Early Career Professional Welcome | |||||
| Room: Careers Zone, Main Exhibition Hall | |||||
| Discovery of risdiplam (evrysdi) - A medicine for the treatment of spinal muscular atrophy | |||||
|
Tue19 Oct11:00am(30 mins)
|
|
|
Dr Hasane Ratni | ||
| Session : Innovations in Chemistry to Discover New Medicines: Approaches to Drugging RNA | |||||
| Room: Hall 1B | |||||
| A Fully Automated Data Analysis Workflow for Gene Expression-Based Screening | |||||
|
Tue19 Oct11:30am(30 mins)
|
|
|
Dr Gabriela Nass Kovacs | ||
| Session : Innovations in Chemistry to Discover New Medicines: Approaches to Drugging RNA | |||||
| Room: Hall 1B | |||||
| mRNA Lightning platform for the discovery of selective small molecule mRNA regulatory drugs | |||||
|
Tue19 Oct12:00pm(30 mins)
|
|
|
Dr Iris Alroy | ||
| Session : Innovations in Chemistry to Discover New Medicines: Approaches to Drugging RNA | |||||
| Room: Hall 1B | |||||
| Dynamic RNAs and Structure-Guided Small Molecule Drug Discovery | |||||
|
Tue19 Oct02:00pm(30 mins)
|
|
|
Dr Isaac Kimsey |
|
Yang Zheng |
| Session : Innovations in Chemistry to Discover New Medicines: Approaches to Drugging RNA | |||||
| Room: Hall 1B | |||||
| DNA-Encoded Library Technology for Drug Discovery | |||||
|
Tue19 Oct02:30pm(5 mins)
|
|
|
Assunta Romano | ||
| Session : Innovations in Chemistry to Discover New Medicines: Approaches to Drugging RNA | |||||
| Room: Hall 1B | |||||
|
Tue19 Oct02:35pm(5 mins)
|
Tecan UK Ltd |
Room: Hall 1B |
| Integrated Drug Discovery: Chemistry and Biology working together to create innovative solutions | |||||
|
Tue19 Oct02:40pm(5 mins)
|
|
|
Dr Catherine Stace | ||
| Session : Innovations in Chemistry to Discover New Medicines: Approaches to Drugging RNA | |||||
| Room: Hall 1B | |||||
| Small activating RNAs from concept to Phase 2 clinical trial | |||||
|
Tue19 Oct02:45pm(30 mins)
|
|
|
Prof Nagy Habib |
|
Prof Vikash Reebye |
| Session : Innovations in Chemistry to Discover New Medicines: Approaches to Drugging RNA | |||||
| Room: Hall 1B | |||||
| X-reactivation as an approach to treating Rett Syndrome | |||||
|
Tue19 Oct04:30pm(30 mins)
|
|
|
Prof Jeannie Lee | ||
| Session : Innovations in Chemistry to Discover New Medicines: Approaches to Drugging RNA | |||||
| Room: Hall 1B | |||||
| High resolution anatomical mapping of gene expression using targeted in situ sequencing | |||||
|
Wed20 Oct11:00am(30 mins)
|
|
|
Dr Mats Nilsson | ||
| Session : Disruptive technologies | |||||
| Room: Hall 1B | |||||
| Development of an Image-Based HCS-Compatible Method for Endothelial Barrier Function Assessment | |||||
|
Wed20 Oct11:30am(30 mins)
|
|
|
Dr Sun Yung | ||
| Session : Disruptive technologies | |||||
| Room: Hall 1B | |||||
| Live cell compatible super resolution fluorescence microscopy for 3D imaging | |||||
|
Wed20 Oct12:00pm(30 mins)
|
|
|
Ilaria Testa |
|
Francesca Pennacchietti |
| Session : Disruptive technologies | |||||
| Room: Hall 1B | |||||
| Single-cell CRISPR screens in primary human T cells | |||||
|
Wed20 Oct12:30pm(15 mins)
|
|
|
Dr Tilmann Buerckstuemmer | ||
| Session : Disruptive technologies | |||||
| Room: Hall 1B | |||||
| R&D at the New Speed of Science: Accelerate your R&D Transformation with Benchling | |||||
|
Wed20 Oct12:45pm(5 mins)
|
|
|
Tali Bloom | ||
| Session : Disruptive technologies | |||||
| Room: Hall 1B | |||||
| Introducing an electronic sensor to measure affinity of intermolecular interactions | |||||
|
Wed20 Oct12:50pm(5 mins)
|
|
|
Dr Sylwia Mankowska | ||
| Session : Disruptive technologies | |||||
| Room: Hall 1B | |||||
| All Human Drug Research Solutions | |||||
|
Wed20 Oct12:55pm(5 mins)
|
|
|
Mr Paul Gallant | ||
| Session : Disruptive technologies | |||||
| Room: Hall 1B | |||||
| Chemical Materials Design | |||||
|
Wed20 Oct02:30pm(30 mins)
|
|
|
Dr Ben Slater | ||
| Session : Disruptive technologies | |||||
| Room: Hall 1B | |||||
| Quantum computing: a new frontier in drug discovery? | |||||
|
Wed20 Oct03:00pm(30 mins)
|
|
|
Sam Genway | ||
| Session : Disruptive technologies | |||||
| Room: Hall 1B | |||||
| A structural biology community assessment of AlphaFold 2 applications | |||||
|
Wed20 Oct03:40pm(30 mins)
|
|
|
Pedro Beltrao | ||
| Session : Disruptive technologies | |||||
| Room: Hall 1B | |||||
| MELLODDY: privacy-preserving federated machine learning across pharma partners | |||||
|
Wed20 Oct04:10pm(30 mins)
|
|
|
Dr Hugo Ceulemans | ||
| Session : Disruptive technologies | |||||
| Room: Hall 1B | |||||
| Alzheimer’s Research UK and its support for translational research. | |||||
|
Tue19 Oct11:00am(30 mins)
|
|
|
Sara Imarisio | ||
| Session : Alzheimer’s Research UK | |||||
| Room: Hall 1C | |||||
| Coding cells for health: building translational disease models for drug discovery and therapeutics | |||||
|
Tue19 Oct11:30am(30 mins)
|
|
|
Dr Marta Rucka |
|
Dr Sara Gomes |
| Session : Alzheimer’s Research UK | |||||
| Room: Hall 1C | |||||
| Identification of tool compounds targeting the SRSF1-dependent nuclear export of pathological C9ORF72-repeat transcripts | |||||
|
Tue19 Oct12:00pm(30 mins)
|
|
|
Miss Lianne Van Beek |
|
Dr Tennore Ramesh |
| Session : Alzheimer’s Research UK | |||||
| Room: Hall 1C | |||||
| Small molecule inhibitors of carboxylesterase Notum to potentiate Wnt signalling | |||||
|
Tue19 Oct02:00pm(30 mins)
|
|
|
Dr Nicky Willis | ||
| Session : Alzheimer’s Research UK | |||||
| Room: Hall 1C | |||||
| Quantifying Morphological Change Using Label-Free Live-Cell Analysis | |||||
|
Tue19 Oct02:30pm(15 mins)
|
|
|
Miss Jasmine Trigg | ||
| Session : Alzheimer’s Research UK | |||||
| Room: Hall 1C | |||||
| Development of eIF2B modulators for the treatment of neurodegenerative disease | |||||
|
Tue19 Oct02:45pm(30 mins)
|
|
Dr Duncan Scott | |||
| Session : Alzheimer’s Research UK | |||||
| Room: Hall 1C | |||||
| Gene editing to treat expanded CAG/CTG repeat disorders | |||||
|
Tue19 Oct03:45pm(30 mins)
|
|
|
Vincent Dion | ||
| Session : Alzheimer’s Research UK | |||||
| Room: Hall 1C | |||||
| The new generation of live cell shipments | |||||
|
Tue19 Oct04:15pm(5 mins)
|
|
|
Mr Simon Myrbäck | ||
| Session : Alzheimer’s Research UK | |||||
| Room: Hall 1C | |||||
| High-Throughput Genome Editing for Disease Models | |||||
|
Tue19 Oct04:20pm(5 mins)
|
|
|
Nick Clare | ||
| Session : Alzheimer’s Research UK | |||||
| Room: Hall 1C | |||||
| Ulysses - Arctoris' end-to-end automation platform for accelerated drug discovery | |||||
|
Tue19 Oct04:25pm(5 mins)
|
|
|
Dr Daniel Thomas | ||
| Session : Alzheimer’s Research UK | |||||
| Room: Hall 1C | |||||
| Novel Therapeutic Targets for Treatment of Neurodegeneration | |||||
|
Tue19 Oct04:30pm(30 mins)
|
|
|
Paul Brennan | ||
| Session : Alzheimer’s Research UK | |||||
| Room: Hall 1C | |||||
| Sir James Black Award Presentation - Anti-CD20, new precision medicines from old targets | |||||
|
Wed20 Oct11:00am(30 mins)
|
|
|
Dr Daren Austin | ||
| Session : The British Pharmacological Society - Opportunities and Challenges of Drugging the Undruggable | |||||
| Room: Hall 1C | |||||
| Ficoll-free primary cell isolation for drug discovery assays | |||||
|
Wed20 Oct11:30am(30 mins)
|
|
|
Lotta Räty | ||
| Session : The British Pharmacological Society - Opportunities and Challenges of Drugging the Undruggable | |||||
| Room: Hall 1C | |||||
| Tracking GPCR signalling- from the outside in one cell at a time | |||||
|
Wed20 Oct12:00pm(30 mins)
|
|
|
Prof Terence Hébert | ||
| Session : The British Pharmacological Society - Opportunities and Challenges of Drugging the Undruggable | |||||
| Room: Hall 1C | |||||
| Enabling drug discovery with diverse lead generation platforms | |||||
|
Wed20 Oct12:30pm(15 mins)
|
|
|
Dr David Madge | ||
| Session : The British Pharmacological Society - Opportunities and Challenges of Drugging the Undruggable | |||||
| Room: Hall 1C | |||||
| Get More Out of BioMAP® Early Screening Data with Tableau | |||||
|
Wed20 Oct12:45pm(5 mins)
|
|
|
Ellen Berg | ||
| Session : The British Pharmacological Society - Opportunities and Challenges of Drugging the Undruggable | |||||
| Room: Hall 1C | |||||
| Bioluminescent Tools & Approaches for RAS Pathway Drug Discovery | |||||
|
Wed20 Oct12:50pm(5 mins)
|
|
Dr Craig Malcolm | |||
| Session : The British Pharmacological Society - Opportunities and Challenges of Drugging the Undruggable | |||||
| Room: Hall 1C | |||||
| Effects of small molecule compounds targeting osteoclasts against RA bone destruction | |||||
|
Wed20 Oct02:30pm(30 mins)
|
|
Prof Yanhui Tan | |||
| Session : The British Pharmacological Society - Opportunities and Challenges of Drugging the Undruggable | |||||
| Room: Hall 1C | |||||
| Bio-inspired nanoformulations for delivery of advanced therapeutics | |||||
|
Wed20 Oct03:00pm(30 mins)
|
|
|
Dr Rongjun Chen | ||
| Session : The British Pharmacological Society - Opportunities and Challenges of Drugging the Undruggable | |||||
| Room: Hall 1C | |||||
| Gaining a career in industry: Learning tips and tricks from the inside | |||||
|
Tue19 Oct10:50am(60 mins)
|
|
Dr Allan Jordan | |||
| Session : Workshop | |||||
| Room: Room 11B - Workshop | |||||
| Inclusive research and experimental design | |||||
|
Tue19 Oct12:30pm(60 mins)
|
|
|
Dr Lilian Hunt | ||
| Session : Workshop | |||||
| Room: Room 11B - Workshop | |||||
| Exceptional Science Presentations: How to Effectively Communicate the Value of Your Work | |||||
|
Tue19 Oct02:00pm(45 mins)
|
|
|
Anita Ramanathan | ||
| Session : Workshop | |||||
| Room: Room 11B - Workshop | |||||
| How to select the best nanoparticle for next-gen drug delivery | |||||
|
Tue19 Oct03:45pm(60 mins)
|
|
|
Dr Philippe Saint-Cricq-Riviere | ||
| Session : Workshop | |||||
| Room: Room 11B - Workshop | |||||
| “The Single-Cell Sequencing Revolution” | |||||
|
Wed20 Oct10:50am(80 mins)
|
|
|
Dr Tilmann Buerckstuemmer | ||
| Session : Workshop | |||||
| Room: Room 11B - Workshop | |||||
| Equality, Diversity and Inclusion: Awareness to action | |||||
|
Wed20 Oct01:00pm(60 mins)
|
|
|
Dr Lilian Hunt | ||
| Session : Workshop | |||||
| Room: Room 11B - Workshop | |||||
| Learn to Learn | |||||
|
Wed20 Oct02:30pm(90 mins)
|
|
Dr Chris Williams | |||
| Session : Workshop | |||||
| Room: Room 11B - Workshop | |||||
| The challenges of cell models: Novel approaches and tools for basic research and drug discovery | |||||
|
Wed20 Oct10:50am(60 mins)
|
|
Zoe Nilsson | |||
| Session : Workshop | |||||
| Room: Room 11C - Workshop | |||||
| ELRIG - Annual Review - Visons & Values | |||||
|
Tue19 Oct08:45am(10 mins)
|
|
|
Mrs Melanie Leveridge | ||
| Session : ELRIG - Opening Session | |||||
| Room: Room 3A | |||||
| ELRIG - Equality, Diversity & Inclusion Guiding Principals | |||||
|
Tue19 Oct08:55am(5 mins)
|
|
Clare Viney | |||
| Session : ELRIG - Opening Session | |||||
| Room: Room 3A | |||||
| ELRIG - Lifetime Achievement Award - A Career In Drug Discovery | |||||
|
Tue19 Oct09:00am(20 mins)
|
|
|
Steve Rees | ||
| Session : ELRIG - Opening Session | |||||
| Room: Room 3A | |||||
| Innovation and Automation during a Pandemic | |||||
|
Tue19 Oct09:20am(50 mins)
|
|
|
Dr Rob Howes | ||
| Session : ELRIG - Opening Session | |||||
| Room: Room 3A | |||||
| Neuropilin-1 facilitates SARS-CoV2 cell entry and infectivity | |||||
|
Tue19 Oct11:00am(30 mins)
|
|
|
Dr Maria Anastasina | ||
| Session : New Approaches in Infection Biology | |||||
| Room: Room 3A | |||||
| Diverse neutralizing SARS-CoV-2 antibodies identified from large-scale synthetic phage libraries target rare epitopes and retain binding to variants of concern. | |||||
|
Tue19 Oct11:30am(30 mins)
|
|
|
Dr Tom Yuan | ||
| Session : New Approaches in Infection Biology | |||||
| Room: Room 3A | |||||
| Functional analysis of Bartonella pathogenicity factors might contribute to novel therapeutic concepts | |||||
|
Tue19 Oct12:00pm(30 mins)
|
|
|
Prof Volkhard Kempf | ||
| Session : New Approaches in Infection Biology | |||||
| Room: Room 3A | |||||
| Targeting the human RED-SMU1 splicing complex as a basis for host-directed anti-influenza therapy | |||||
|
Tue19 Oct02:00pm(30 mins)
|
|
Dr Nadia Naffakh | |||
| Session : New Approaches in Infection Biology | |||||
| Room: Room 3A | |||||
| Introducing TRFID, a UK-leading BSL3 translation biology facility for Infectious Diseases at Alderley Park | |||||
|
Tue19 Oct02:30pm(5 mins)
|
|
|
Dr Helen Bright | ||
| Session : New Approaches in Infection Biology | |||||
| Room: Room 3A | |||||
| LabLogic Life Sciences range has something for everyone | |||||
|
Tue19 Oct02:35pm(5 mins)
|
|
|
Lucy Farmer | ||
| Session : New Approaches in Infection Biology | |||||
| Room: Room 3A | |||||
| FidaBio: Characterizing Biomolecular behaviour by measuring and monitoring changes in hydrodynamic radius | |||||
|
Tue19 Oct02:40pm(5 mins)
|
|
|
Jo Walter | ||
| Session : New Approaches in Infection Biology | |||||
| Room: Room 3A | |||||
| Studies of the membrane-bound pyrophosphatase as a potential drug target against protist parasites | |||||
|
Tue19 Oct02:45pm(30 mins)
|
|
|
Dr Keni Vidilaseris | ||
| Session : New Approaches in Infection Biology | |||||
| Room: Room 3A | |||||
| Developing inhibitors that block adhesin-collagen interactions | |||||
|
Tue19 Oct03:45pm(30 mins)
|
|
|
Prof Dirk Linke | ||
| Session : New Approaches in Infection Biology | |||||
| Room: Room 3A | |||||
| PerkinElmer’s Tools to study virus-host interaction and virus inhibition | |||||
|
Tue19 Oct04:15pm(15 mins)
|
|
|
Dr Louise Affleck | ||
| Session : New Approaches in Infection Biology | |||||
| Room: Room 3A | |||||
| Inhibition of bacterial virulence as an alternative to antibiotic treatment: Pseudomonas aeruginosa elastase as a target for antivirulence therapy | |||||
|
Tue19 Oct04:30pm(30 mins)
|
|
|
Dr Martin Everett | ||
| Session : New Approaches in Infection Biology | |||||
| Room: Room 3A | |||||
| Looking ahead: what is next for AI in drug discovery? | |||||
|
Wed20 Oct09:00am(50 mins)
|
|
Guido Lanza | |||
| Session : Plenary Keynote Presentation | |||||
| Room: Room 3A | |||||
| Mind the gap… making a career out of building bridges | |||||
|
Wed20 Oct09:50am(20 mins)
|
|
|
Dr Laura Ajram | ||
| Session : Early Career Professional Impact Award - Sponsored by SelectScience | |||||
| Room: Room 3A | |||||
| High-throughput proteomics for gene function prediction, target discovery and precision medicine | |||||
|
Wed20 Oct11:00am(30 mins)
|
|
|
Markus Ralser | ||
| Session : Screening Innovation to Enhance Drug Discovery - sponsored by Domainex | |||||
| Room: Room 3A | |||||
| Automated High-Speed and High-Throughput Screening with the ZE5 Cell Analyzer. | |||||
|
Wed20 Oct11:30am(30 mins)
|
|
|
Dr Richard Cuthbert | ||
| Session : Screening Innovation to Enhance Drug Discovery - sponsored by Domainex | |||||
| Room: Room 3A | |||||
| Automating Image Analysis with Deep Learning to Accelerate Drug Discovery and Increase Mechanistic Insight | |||||
|
Wed20 Oct12:00pm(30 mins)
|
|
|
Dr James Robinson | ||
| Session : Screening Innovation to Enhance Drug Discovery - sponsored by Domainex | |||||
| Room: Room 3A | |||||
| CETSA® Navigate HT: A new paradigm for high-throughput screening | |||||
|
Wed20 Oct12:30pm(15 mins)
|
|
|
Fredrik Rahm | ||
| Session : Screening Innovation to Enhance Drug Discovery - sponsored by Domainex | |||||
| Room: Room 3A | |||||
| Accelerating the Next Generation of Immune Medicine with Fully Automated High-Plex Cellular Proteomics | |||||
|
Wed20 Oct12:45pm(5 mins)
|
|
|
Mr Mourad Ferhat | ||
| Session : Screening Innovation to Enhance Drug Discovery - sponsored by Domainex | |||||
| Room: Room 3A | |||||
| #GEEKE SPEAK: If u * do wat y’ve * done, y’ll * get wat ye * got (*=?) | |||||
|
Wed20 Oct12:50pm(5 mins)
|
|
|
Mr Gary Allenby | ||
| Session : Screening Innovation to Enhance Drug Discovery - sponsored by Domainex | |||||
| Room: Room 3A | |||||
| Quantification of molecular interactions by a novel ligand-induced spectral shift technology | |||||
|
Wed20 Oct12:55pm(5 mins)
|
|
|
Dr Ravindra Chaudhari | ||
| Session : Screening Innovation to Enhance Drug Discovery - sponsored by Domainex | |||||
| Room: Room 3A | |||||
| Generation of fully human antibodies using high throughput IntelliSelect® Technology Platforms at LifeArc | |||||
|
Wed20 Oct02:30pm(30 mins)
|
|
Dr Preeti Bakrania | |||
| Session : Screening Innovation to Enhance Drug Discovery - sponsored by Domainex | |||||
| Room: Room 3A | |||||
| Alignment of Chemogenomic and Functional Genomic screening for target ID | |||||
|
Wed20 Oct03:00pm(30 mins)
|
|
Dr Joanna Redmond | |||
| Session : Screening Innovation to Enhance Drug Discovery - sponsored by Domainex | |||||
| Room: Room 3A | |||||
| A Huntington’s disease embryonic stem cell phenotypic HTS to identify small molecule modulators of mutant HTT | |||||
|
Wed20 Oct03:40pm(30 mins)
|
|
Dr Marta Stebbeds | |||
| Session : Screening Innovation to Enhance Drug Discovery - sponsored by Domainex | |||||
| Room: Room 3A | |||||
| High-throughput PROTAC synthesis for direct, biological assaying | |||||
|
Wed20 Oct04:10pm(30 mins)
|
|
David Battersby | |||
| Session : Screening Innovation to Enhance Drug Discovery - sponsored by Domainex | |||||
| Room: Room 3A | |||||
| Q-POCTM, a paradigm shift in rapid multiplex molecular diagnostics | |||||
|
Tue19 Oct11:00am(30 mins)
|
|
|
Jonathan OHalloran | ||
| Session : Diagnostic Testing and Biomarkers - The New Normal? - sponsored by Ziath Ltd | |||||
| Room: Room 3B | |||||
| Transforming Drug Discovery Through Precision Research | |||||
|
Tue19 Oct11:30am(30 mins)
|
|
|
Stephen Hague | ||
| Session : Diagnostic Testing and Biomarkers - The New Normal? - sponsored by Ziath Ltd | |||||
| Room: Room 3B | |||||
| A luminescent reporter cell line for authentic SARS-CoV-2 infection and neutralising antibody activity | |||||
|
Tue19 Oct12:00pm(30 mins)
|
|
|
Dr Nick Matheson | ||
| Session : Diagnostic Testing and Biomarkers - The New Normal? - sponsored by Ziath Ltd | |||||
| Room: Room 3B | |||||
| Diagnostics for epidemics, pandemics and neglected tropical disease | |||||
|
Tue19 Oct02:00pm(30 mins)
|
|
|
Dr Emily Adams | ||
| Session : Diagnostic Testing and Biomarkers - The New Normal? - sponsored by Ziath Ltd | |||||
| Room: Room 3B | |||||
| Assist Plus | |||||
|
Tue19 Oct02:35pm(5 mins)
|
|
|
Sharon Barnard | ||
| Session : Diagnostic Testing and Biomarkers - The New Normal? - sponsored by Ziath Ltd | |||||
| Room: Room 3B | |||||
| EMERGING DIAGNOSTIC TECHNOLOGIES IN CLINICAL MICROBIOLOGY | |||||
|
Tue19 Oct02:45pm(30 mins)
|
|
|
Dr Alex Van Belkum | ||
| Session : Diagnostic Testing and Biomarkers - The New Normal? - sponsored by Ziath Ltd | |||||
| Room: Room 3B | |||||
| Computer literate? Novel AI based reading of lateral flow devices | |||||
|
Tue19 Oct03:45pm(30 mins)
|
|
|
Daniel Wise | ||
| Session : Diagnostic Testing and Biomarkers - The New Normal? - sponsored by Ziath Ltd | |||||
| Room: Room 3B | |||||
| Don't Let the Antibody be a Variable in Your Assay | |||||
|
Tue19 Oct04:20pm(5 mins)
|
|
|
Mr Mark Twigden | ||
| Session : Diagnostic Testing and Biomarkers - The New Normal? - sponsored by Ziath Ltd | |||||
| Room: Room 3B | |||||
| Introducing Cytek cFluorTM Reagents and Assays | |||||
|
Tue19 Oct04:25pm(5 mins)
|
|
|
Michelle Jackson | ||
| Session : Diagnostic Testing and Biomarkers - The New Normal? - sponsored by Ziath Ltd | |||||
| Room: Room 3B | |||||
| How to build a mobile lab for genomic surveillance of viral outbreaks | |||||
|
Tue19 Oct04:30pm(30 mins)
|
|
|
Dr Joshua Quick | ||
| Session : Diagnostic Testing and Biomarkers - The New Normal? - sponsored by Ziath Ltd | |||||
| Room: Room 3B | |||||
| The MRC’s COVID-19 Research Response | |||||
|
Wed20 Oct11:00am(30 mins)
|
|
|
Jonathan Pearce | ||
| Session : Innovative Strategies Supporting Drug Discovery | |||||
| Room: Room 3B | |||||
| Innovation Strategies Supporting Drug Discovery | |||||
|
Wed20 Oct11:30am(30 mins)
|
|
|
Dr Andrew Scott | ||
| Session : Innovative Strategies Supporting Drug Discovery | |||||
| Room: Room 3B | |||||
| Improving diversity in health research and clinical trials | |||||
|
Wed20 Oct12:00pm(30 mins)
|
|
|
Annette Crosse | ||
| Session : Innovative Strategies Supporting Drug Discovery | |||||
| Room: Room 3B | |||||
| De-risking drug development by early translational pharmacology | |||||
|
Wed20 Oct12:30pm(15 mins)
|
|
|
Dr Charlotte Kopitz | ||
| Session : Innovative Strategies Supporting Drug Discovery | |||||
| Room: Room 3B | |||||
| Connected Lab Automation for Dynamic Data Exchange | |||||
|
Wed20 Oct12:45pm(5 mins)
|
|
|
Mr Matt Taylor | ||
| Session : Innovative Strategies Supporting Drug Discovery | |||||
| Room: Room 3B | |||||
| Traceability, accountability, and data integrity: GxP software for image acquisition and analysis | |||||
|
Wed20 Oct12:50pm(5 mins)
|
|
|
Dr Mark Graham | ||
| Session : Innovative Strategies Supporting Drug Discovery | |||||
| Room: Room 3B | |||||
| Data Management for Collaborative Drug Discovery | |||||
|
Wed20 Oct12:55pm(5 mins)
|
|
|
Miss Tamsin Lamont | ||
| Session : Innovative Strategies Supporting Drug Discovery | |||||
| Room: Room 3B | |||||
| Democratising Drug Discovery – Widening Access to Expertise and Technologies | |||||
|
Wed20 Oct02:30pm(30 mins)
|
|
|
Prof Peter Simpson | ||
| Session : Innovative Strategies Supporting Drug Discovery | |||||
| Room: Room 3B | |||||
| Open drug discovery on the edge - the COVID Mooonshot's quest for an antiviral pill | |||||
|
Wed20 Oct03:00pm(30 mins)
|
|
Frank von Delft | |||
| Session : Innovative Strategies Supporting Drug Discovery | |||||
| Room: Room 3B | |||||
| 'Virtual Reality’ – Adding a New Dimension to Drug Design | |||||
|
Wed20 Oct03:40pm(30 mins)
|
|
|
Timur Avkiran | ||
| Session : Innovative Strategies Supporting Drug Discovery | |||||
| Room: Room 3B | |||||
| Transforming Research and Medicine through Synthetic Biology | |||||
|
Wed20 Oct04:10pm(30 mins)
|
|
|
Helen Horton | ||
| Session : Innovative Strategies Supporting Drug Discovery | |||||
| Room: Room 3B | |||||
